Yayın:
Efficacy and Tolerability of Current Treatments for Hormone-Refractory Prostate Cancer Patients with Visceral Metastases

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorKaplan Ma
dc.contributor.authorMustafa Karaağaç
dc.contributor.authorNeslihan Özyurt
dc.contributor.authorAli Murat Tatlı
dc.contributor.authorAli Kaya
dc.contributor.authorSerkan Menekşe
dc.contributor.authorEngin Kut
dc.contributor.authorSinan Koca
dc.contributor.authorÖzlem Nuray Sever
dc.contributor.authorI. S. Yasin
dc.contributor.authorSenar Ebinç
dc.contributor.authorEsra Zeynelgil
dc.contributor.authorAbdullah Sakin
dc.contributor.authorN. S. Turhal
dc.contributor.authorAbdurrahman Işıkdoğan
dc.contributor.orcid0000-0002-7931-2941
dc.contributor.orcid0000-0003-0882-0524
dc.contributor.orcid0000-0003-4533-0620
dc.contributor.orcid0000-0002-1404-8983
dc.contributor.orcid0000-0001-9696-1102
dc.contributor.orcid0000-0001-7182-6641
dc.contributor.orcid0000-0002-2134-2128
dc.contributor.orcid0000-0002-5328-5607
dc.contributor.orcid0000-0002-8370-1587
dc.contributor.orcid0000-0003-3462-9360
dc.contributor.orcid0000-0002-0878-6525
dc.contributor.orcid0000-0001-7200-9440
dc.contributor.orcid0000-0003-2538-8569
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-7451-7286
dc.date.accessioned2025-11-13T20:30:23Z
dc.date.issued2021-02-26
dc.identifier.doihttps://doi.org/10.2217/fon-2020-1032
dc.identifier.endpage1624
dc.identifier.issn1479-6694
dc.identifier.issue13
dc.identifier.openalexW3132964443
dc.identifier.startpage1611
dc.identifier.urihttps://hdl.handle.net/11421/12020
dc.identifier.urihttps://doi.org/10.2217/fon-2020-1032
dc.identifier.volume17
dc.language.isoen
dc.relation.ispartofFuture Oncology
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectEnzalutamide
dc.subjectDocetaxel
dc.subjectTolerability
dc.subjectProstate cancer
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectCabazitaxel
dc.subjectRefractory (planetary science)
dc.subjectChemotherapy
dc.subjectAndrogen deprivation therapy
dc.subjectCancer
dc.subjectUrology
dc.subjectAdverse effect
dc.subjectAndrogen receptor
dc.subject.sdg3
dc.titleEfficacy and Tolerability of Current Treatments for Hormone-Refractory Prostate Cancer Patients with Visceral Metastases
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications